Roche receives CE Mark for blood test to identify tuberculosis infection
The Elecsys IGRA TB test expands global access to tuberculosis infection testing, advancing progress toward the World Health…
Roche receives CE mark for new Elecsys NfL blood test to detect neuroinflammation in multiple sclerosis
The Elecsys NfL blood test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple…
Leadership Shift and Strategic Acquisition Mark Zurich Insurance’s Path
Leadership, Shift
23.03.2026 – 00:37:11 | boerse-global.de
Zurich acquires Generali’s Irish P&C portfolio for…
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…